Home » Topics » Regulatory

Regulatory
RSS

Cipralex approved in Sweden; European mutual recognition procedure initiated

Dec. 11, 2001

FDA approval for intravenous formulation of Avelox

Dec. 10, 2001

Antizol receives additional approval in Canada for methanol poisoning

Dec. 10, 2001

Tetracycline antibiotic finds new use as neuroprotective agent 30 years later

Dec. 7, 2001

First approval obtained for new BPH therapeutic from GSK

Dec. 4, 2001

Teveten HCT receives marketing approval in U.S.

Dec. 4, 2001

FDA clears injectable antibiotic Invanz

Dec. 3, 2001

FDA marketing approval granted for improved form of Ritalin for ADHD

Dec. 3, 2001

Canadian approval for Fludara as NHL treatment

Dec. 3, 2001

Zenapax enters phase II trial in patients with chronic asthma

Dec. 3, 2001

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...